206 related articles for article (PubMed ID: 8662907)
21. Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts.
Birge RB; Fajardo JE; Reichman C; Shoelson SE; Songyang Z; Cantley LC; Hanafusa H
Mol Cell Biol; 1993 Aug; 13(8):4648-56. PubMed ID: 7687742
[TBL] [Abstract][Full Text] [Related]
22. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
[TBL] [Abstract][Full Text] [Related]
23. Emerging components of the Crk oncogene product: the first identified adaptor protein.
Matsuda M; Kurata T
Cell Signal; 1996 Aug; 8(5):335-40. PubMed ID: 8911681
[TBL] [Abstract][Full Text] [Related]
24. Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk.
Wu X; Knudsen B; Feller SM; Zheng J; Sali A; Cowburn D; Hanafusa H; Kuriyan J
Structure; 1995 Feb; 3(2):215-26. PubMed ID: 7735837
[TBL] [Abstract][Full Text] [Related]
25. A potential SH3 domain-binding site in the Crk SH2 domain.
Anafi M; Rosen MK; Gish GD; Kay LE; Pawson T
J Biol Chem; 1996 Aug; 271(35):21365-74. PubMed ID: 8702917
[TBL] [Abstract][Full Text] [Related]
26. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites.
Ren R; Ye ZS; Baltimore D
Genes Dev; 1994 Apr; 8(7):783-95. PubMed ID: 7926767
[TBL] [Abstract][Full Text] [Related]
27. A 31-amino-acid N-terminal extension regulates c-Crk binding to tyrosine-phosphorylated proteins.
Fajardo JE; Birge RB; Hanafusa H
Mol Cell Biol; 1993 Dec; 13(12):7295-302. PubMed ID: 7504172
[TBL] [Abstract][Full Text] [Related]
28. Physiological signals and oncogenesis mediated through Crk family adapter proteins.
Feller SM; Posern G; Voss J; Kardinal C; Sakkab D; Zheng J; Knudsen BS
J Cell Physiol; 1998 Dec; 177(4):535-52. PubMed ID: 10092207
[TBL] [Abstract][Full Text] [Related]
29. Tyrosine-phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze Crk-phosphotyrosine-dependent interactions in vitro.
Birge RB; Fajardo JE; Mayer BJ; Hanafusa H
J Biol Chem; 1992 May; 267(15):10588-95. PubMed ID: 1375224
[TBL] [Abstract][Full Text] [Related]
30. C-terminal SH3 domain of CrkII regulates the assembly and function of the DOCK180/ELMO Rac-GEF.
Akakura S; Kar B; Singh S; Cho L; Tibrewal N; Sanokawa-Akakura R; Reichman C; Ravichandran KS; Birge RB
J Cell Physiol; 2005 Jul; 204(1):344-51. PubMed ID: 15700267
[TBL] [Abstract][Full Text] [Related]
31. SH2 and SH3-containing adaptor proteins: redundant or independent mediators of intracellular signal transduction.
Birge RB; Knudsen BS; Besser D; Hanafusa H
Genes Cells; 1996 Jul; 1(7):595-613. PubMed ID: 9078388
[TBL] [Abstract][Full Text] [Related]
32. Grb2 SH3 binding to peptides from Sos: evaluation of a general model for SH3-ligand interactions.
Simon JA; Schreiber SL
Chem Biol; 1995 Jan; 2(1):53-60. PubMed ID: 9383403
[TBL] [Abstract][Full Text] [Related]
33. The proto-oncogene product c-Cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells.
Odai H; Sasaki K; Iwamatsu A; Hanazono Y; Tanaka T; Mitani K; Yazaki Y; Hirai H
J Biol Chem; 1995 May; 270(18):10800-5. PubMed ID: 7537740
[TBL] [Abstract][Full Text] [Related]
34. p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene.
Salgia R; Pisick E; Sattler M; Li JL; Uemura N; Wong WK; Burky SA; Hirai H; Chen LB; Griffin JD
J Biol Chem; 1996 Oct; 271(41):25198-203. PubMed ID: 8810278
[TBL] [Abstract][Full Text] [Related]
35. Intersectin, a novel adaptor protein with two Eps15 homology and five Src homology 3 domains.
Yamabhai M; Hoffman NG; Hardison NL; McPherson PS; Castagnoli L; Cesareni G; Kay BK
J Biol Chem; 1998 Nov; 273(47):31401-7. PubMed ID: 9813051
[TBL] [Abstract][Full Text] [Related]
36. T cell receptor-mediated tyrosine phosphorylation of Cas-L, a 105-kDa Crk-associated substrate-related protein, and its association of Crk and C3G.
Ohashi Y; Tachibana K; Kamiguchi K; Fujita H; Morimoto C
J Biol Chem; 1998 Mar; 273(11):6446-51. PubMed ID: 9497377
[TBL] [Abstract][Full Text] [Related]
37. The signal transduction through Grb2/Ash in hematopoietic cells.
Odai H; Hanazono Y; Sasaki K; Iwamatu A; Yazaki Y; Hirai H
Leukemia; 1997 Apr; 11 Suppl 3():405-7. PubMed ID: 9209406
[TBL] [Abstract][Full Text] [Related]
38. The proto-oncogene product c-Crk associates with insulin receptor substrate-1 and 4PS. Modulation by insulin growth factor-I (IGF) and enhanced IGF-I signaling.
Beitner-Johnson D; Blakesley VA; Shen-Orr Z; Jimenez M; Stannard B; Wang LM; Pierce J; LeRoith D
J Biol Chem; 1996 Apr; 271(16):9287-90. PubMed ID: 8621590
[TBL] [Abstract][Full Text] [Related]
39. Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide.
Donaldson LW; Gish G; Pawson T; Kay LE; Forman-Kay JD
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14053-8. PubMed ID: 12384576
[TBL] [Abstract][Full Text] [Related]
40. Crk-associated substrate p130(Cas) interacts with nephrocystin and both proteins localize to cell-cell contacts of polarized epithelial cells.
Donaldson JC; Dempsey PJ; Reddy S; Bouton AH; Coffey RJ; Hanks SK
Exp Cell Res; 2000 Apr; 256(1):168-78. PubMed ID: 10739664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
